C.difficile Observational Study

Study identifier:D8820C00001

ClinicalTrials.gov identifier:NCT06277999

EudraCT identifier:N/A

CTIS identifier:N/A

Recruiting

Official Title

An Observational Study in Adults with Clostridioides difficile Infection to Determine the Feasibility and Logistics of Biospecimen Collection, Transportation and Testing at Select US Study Sites

Medical condition

Clostridium Infections

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

100

Study type

Observational

Age

18 Years - 130 Years

Date

Study Start Date: 22 Apr 2024
Estimated Primary Completion Date: 11 Feb 2025
Estimated Study Completion Date: 11 Feb 2025

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Sept 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria